Presentation is loading. Please wait.

Presentation is loading. Please wait.

CLL-1 expression in patients with AML and normal donors.

Published byΒηθζαθά Φιλιππίδης Modified over 5 years ago

Similar presentations

Presentation on theme: "CLL-1 expression in patients with AML and normal donors."— Presentation transcript:

1 CLL-1 expression in patients with AML and normal donors.
CLL-1 expression in patients with AML and normal donors. A, Comparison of CLL-1 (open circle) and CD33 (open square) expression level in 70 patients with AML. Expression level was normalized to antibody bound by Quantibrite beads and PE molecule/antibody ratio. Solid line, median value of expression. B, CLL-1 expression in normal leukocytes (black open square) and patients with AML (cayenne solid circle). Solid line, median value of expression. C, Representative expression of CLL-1 in different stage of hematopoietic stem cell and progenitor cells (HSPC). CLP, common lymphoid progenitor; MEP, megakaryocyte–erythroid progenitor. Each histogram shows CLL-1 expression (solid red) overlaid with isotype control (gray shade). Bing Zheng et al. Clin Cancer Res 2019;25: ©2019 by American Association for Cancer Research

Download ppt "CLL-1 expression in patients with AML and normal donors."

Similar presentations

The expression and signaling of FGFR3 in WM cells.

The expression and signaling of FGFR3 in WM cells.
Expression of immune checkpoint molecules on leukocytes and tumor cells at baseline and in response to selinexor. Expression of immune checkpoint molecules.

Expression of immune checkpoint molecules on leukocytes and tumor cells at baseline and in response to selinexor. Expression of immune checkpoint molecules.
Melanoma donor (MD) NK cells are functionally impaired/exhausted.

Melanoma donor (MD) NK cells are functionally impaired/exhausted.
CD25 expression is associated with unfavorable clinical outcome.

CD25 expression is associated with unfavorable clinical outcome.
Cancer Stem Cells in Hematopoietic Malignancies

Cancer Stem Cells in Hematopoietic Malignancies
Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen.

Up-regulation of NK Cell Activating Receptors Following Allogeneic Hematopoietic Stem Cell Transplantation under a Lymphodepleting Reduced Intensity Regimen.
NP23 leukemias exhibit Hox/Meis1 stem cell–like gene expression signatures that are enriched in human HSPC and AML genesets. NP23 leukemias exhibit Hox/Meis1.

NP23 leukemias exhibit Hox/Meis1 stem cell–like gene expression signatures that are enriched in human HSPC and AML genesets. NP23 leukemias exhibit Hox/Meis1.
Volume 8, Issue 6, Pages (June 2017)

Volume 8, Issue 6, Pages (June 2017)
Human Treg cells express PlexinB1.

Human Treg cells express PlexinB1.
Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.

Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.
The absence of ADCC by nivolumab in vitro.

The absence of ADCC by nivolumab in vitro.
Response of monocytes to hY4 delivery and cytokine levels in CLL serum

Response of monocytes to hY4 delivery and cytokine levels in CLL serum
Volume 17, Issue 4, Pages (October 2002)

Volume 17, Issue 4, Pages (October 2002)
Quantification of MHC-I, β2m, and T-cell subsets.

Quantification of MHC-I, β2m, and T-cell subsets.
Figure 1 CD52 expression on innate myeloid and lymphoid cell subsets

Figure 1 CD52 expression on innate myeloid and lymphoid cell subsets
Relationship between blood cell and plasma miRNA expression among published circulating cancer biomarkers. Relationship between blood cell and plasma miRNA.

Relationship between blood cell and plasma miRNA expression among published circulating cancer biomarkers. Relationship between blood cell and plasma miRNA.
Frequency and kinetics of killer cell apoptosis are dependent on functional conjugations with multiple NALM-6 tumor cells. Frequency and kinetics of killer.

Frequency and kinetics of killer cell apoptosis are dependent on functional conjugations with multiple NALM-6 tumor cells. Frequency and kinetics of killer.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.

Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Correlation between MRP1 mRNA expression and CF efflux-blocking factors of MK-571 (A) and between MDR1 mRNA expression and Rh123 efflux-blocking factors.

Correlation between MRP1 mRNA expression and CF efflux-blocking factors of MK-571 (A) and between MDR1 mRNA expression and Rh123 efflux-blocking factors.
Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined.

Activating mutation of Ras is associated with CDCP1 expression in NSCLC. A, NSCLC cell lines with Ras + B-Raf mutations and wild-type Ras were examined.

Similar presentations

Ads by Google